Clinical Trial Update: Effects of L-Carnitine in Amyotrophic Lateral Sclerosis Patients With CHCHD10 Mutations [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the effects of L-Carnitine in ALS patients with CHCHD10 mutations has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Drugs mentioned

• L-carnitine (L-carnitine)

Snippet

Sponsor: ChaodongWang | Conditions: Amyotrophic Lateral Sclerosis (ALS) | Phase 4 | Status: COMPLETED